Position in LXRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$285,816
+$269,001 QoQ
Shares Held
119,090
+1004.8% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#49
of 149 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026State of Wyoming holds $40,938,454 across 171 Biotechnology names. LXRX ranks #37 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
35,525 | $4,027,114 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,698 | $2,478,669 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
4,767 | $1,771,750 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
9,446 | $1,769,046 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
11,780 | $1,350,812 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,410 | $1,294,049 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
48,794 | $1,234,488 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
2,768 | $926,698 |
All Filings in LXRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,816 | 119,090 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $16,815 | 10,779 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $69,656 | 60,571 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $11,510 | 8,526 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||